Core Insights - Scienture Holdings, Inc. is participating in the 8th Annual Conference of The Society for the Study of Xenobiotics (SSX) India, focusing on drug discovery and development [1][3] - Dr. Narasimhan Mani will present on technology-driven product innovations and market strategies to enhance patient access to novel therapies [2][5] - The SSX conference aims to provide a platform for knowledge exchange among scientists in the DMPK/ADMET fields, showcasing trends in the global pharmaceutical industry [3][7] Company Overview - Scienture Holdings, Inc. operates through its subsidiaries, focusing on delivering novel specialty pharmaceutical products to meet unmet market needs [5] - The company is involved in various therapeutic areas and market segments, including government organizations, hospitals, and independent pharmacies [5] Conference Details - The SSX 2025 Conference will take place from January 23-25, 2025, at BITS Pilani, Hyderabad Campus, featuring expert panels and presentations [1][4] - The event has seen a steady increase in participation from industry experts, scientists, and students over the years [3]
Scienture Holdings, Inc. Announces Dr. Narasimhan Mani's Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics